The stock of SeaStar Medical Holding Corp (ICU) has gone down by -24.12% for the week, with a -16.85% drop in the past month and a -37.84% drop in the past quarter. The volatility ratio for the week is 9.83%, and the volatility levels for the past 30 days are 10.85% for ICU. The simple moving average for the past 20 days is -22.51% for ICU’s stock, with a -56.38% simple moving average for the past 200 days.
Is It Worth Investing in SeaStar Medical Holding Corp (NASDAQ: ICU) Right Now?
The 36-month beta value for ICU is also noteworthy at -0.96. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ICU is 3.69M, and at present, short sellers hold a 4.37% of that float. The average trading volume of ICU on August 14, 2024 was 311.96K shares.
ICU) stock’s latest price update
SeaStar Medical Holding Corp (NASDAQ: ICU)’s stock price has gone decline by -16.51 in comparison to its previous close of 7.27, however, the company has experienced a -24.12% decrease in its stock price over the last five trading days. accesswire.com reported 2024-08-13 that The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation (“SeaStar” or “the Company”) (NASDAQ: ICU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between October 31, 2022 and March 26, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before September 6, 2024.
ICU Trading at -18.61% from the 50-Day Moving Average
After a stumble in the market that brought ICU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.86% of loss for the given period.
Volatility was left at 10.85%, however, over the last 30 days, the volatility rate increased by 9.83%, as shares sank -22.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.63% lower at present.
During the last 5 trading sessions, ICU fell by -24.12%, which changed the moving average for the period of 200-days by -71.40% in comparison to the 20-day moving average, which settled at $7.75. In addition, SeaStar Medical Holding Corp saw -45.15% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICU starting from Van Heel Kenneth, who purchase 100,000 shares at the price of $0.40 back on Nov 22 ’23. After this action, Van Heel Kenneth now owns 116,400 shares of SeaStar Medical Holding Corp, valued at $40,000 using the latest closing price.
Stock Fundamentals for ICU
The total capital return value is set at 7.12. Equity return is now at value -103.15, with -605.20 for asset returns.
Based on SeaStar Medical Holding Corp (ICU), the company’s capital structure generated -9.75 points at debt to capital in total, while cash flow to debt ratio is standing at -2.83. The debt to equity ratio resting at -0.91. The interest coverage ratio of the stock is -26.89.
Currently, EBITDA for the company is -14.21 million with net debt to EBITDA at 0.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.68.
Conclusion
In summary, SeaStar Medical Holding Corp (ICU) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
